Terakawa M - Search Results

1

Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5.

Yamamura T, Horinouchi T, Adachi T, Terakawa M, Takaoka Y, Omachi K, Takasato M, Takaishi K, Shoji T, Onishi Y, Kanazawa Y, Koizumi M, Tomono Y, Sugano A, Shono A, Minamikawa S, Nagano C, Sakakibara N, Ishiko S, Aoto Y, Kamura M, Harita Y, Miura K, Kanda S, Morisada N, Rossanti R, Ye MJ, Nozu Y, Matsuo M, Kai H, Iijima K, Nozu K. Yamamura T, et al. Among authors: terakawa m. Nat Commun. 2020 Jun 2;11(1):2777. doi: 10.1038/s41467-020-16605-x. Nat Commun. 2020. PMID: 32488001 Free PMC article.

2

Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers.

Katayama K, Tsunemi T, Miyazaki K, Uoto K, Yoshioka R, Terashima H, Terakawa M, Yamashiro K, Haruyama M, Maeda H, Makino T. Katayama K, et al. Among authors: terakawa m. Bioorg Med Chem Lett. 2020 Oct 1;30(19):127425. doi: 10.1016/j.bmcl.2020.127425. Epub 2020 Jul 24. Bioorg Med Chem Lett. 2020. PMID: 32717372

3

Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.

Tomoo T, Nakatsuka T, Katayama T, Hayashi Y, Fujieda Y, Terakawa M, Nagahira K. Tomoo T, et al. Among authors: terakawa m. J Med Chem. 2014 Sep 11;57(17):7244-62. doi: 10.1021/jm500494y. Epub 2014 Aug 26. J Med Chem. 2014. PMID: 25102418

4

Phenotypic-screening generates active novel fetal globin-inducers that downregulate Bcl11a in a monkey model.

Makino T, Haruyama M, Katayama K, Terashima H, Tsunemi T, Miyazaki K, Terakawa M, Yamashiro K, Yoshioka R, Maeda H. Makino T, et al. Among authors: terakawa m. Biochem Pharmacol. 2020 Jan;171:113717. doi: 10.1016/j.bcp.2019.113717. Epub 2019 Nov 18. Biochem Pharmacol. 2020. PMID: 31751536

5

Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.

Terakawa M, Fujieda Y, Tomimori Y, Muto T, Tanaka T, Maruoka H, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y. Terakawa M, et al. Eur J Pharmacol. 2008 Dec 28;601(1-3):186-91. doi: 10.1016/j.ejphar.2008.10.040. Epub 2008 Oct 29. Eur J Pharmacol. 2008. PMID: 18996112

6

Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patients.

Ogata A, Fujieda Y, Terakawa M, Muto T, Tanaka T, Maruoka H, Nagahira K, Fukuda Y, Tomimori Y, Watanabe N. Ogata A, et al. Among authors: terakawa m. Int Immunopharmacol. 2011 Oct;11(10):1628-32. doi: 10.1016/j.intimp.2011.05.025. Epub 2011 Jun 12. Int Immunopharmacol. 2011. PMID: 21642018

7

Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis.

Nakamura R, Makino T, Hanada T, Terakawa M, Nagahira K, Yamate J, Shiraishi H, Motomura M. Nakamura R, et al. Among authors: terakawa m. J Neuroimmunol. 2018 Jul 15;320:64-75. doi: 10.1016/j.jneuroim.2018.04.014. Epub 2018 Apr 26. J Neuroimmunol. 2018. PMID: 29759142

8

Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.

Makino T, Nakamura R, Terakawa M, Muneoka S, Nagahira K, Nagane Y, Yamate J, Motomura M, Utsugisawa K. Makino T, et al. Among authors: terakawa m. PLoS One. 2017 Oct 17;12(10):e0185976. doi: 10.1371/journal.pone.0185976. eCollection 2017. PLoS One. 2017. PMID: 29040265 Free PMC article.

9

Oral administration of chymase inhibitor improves dermatitis in NC/Nga mice.

Watanabe N, Tomimori Y, Terakawa M, Ishiwata K, Wada A, Muto T, Tanaka T, Maruoka H, Nagahira K, Nakatsuka T, Fukuda Y. Watanabe N, et al. Among authors: terakawa m. J Invest Dermatol. 2007 Apr;127(4):971-3. doi: 10.1038/sj.jid.5700708. Epub 2007 Jan 25. J Invest Dermatol. 2007. PMID: 17255959 Free article. No abstract available.

10

Epitope mapping of monoclonal antibodies to tumor necrosis factor-alpha by synthetic peptide approach.

Nagahira K, Fukuda Y, Terakawa M, Hashino J, Nasu T, Nakazato H, Nakanishi T. Nagahira K, et al. Among authors: terakawa m. Immunol Lett. 1995 May;46(1-2):135-41. doi: 10.1016/0165-2478(95)00031-y. Immunol Lett. 1995. PMID: 7590909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page